Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial

Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL

(2014) M. J. Benson et al.   JOURNAL OF IMMUNOLOGY

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial

(2011) M. C. Genovese et al.   ARTHRITIS AND RHEUMATISM

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I

(2010) J. Funovits et al.   ANNALS OF THE RHEUMATIC DISEASES

Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers

(2010) Thomas Dörner et al.   PHARMACOLOGY & THERAPEUTICS

Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis

(2009) C Bracewell et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus

(2009) I. Nestorov et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Rheumatoid arthritis

(2009) Lars Klareskog et al.   LANCET

Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials

(2008) Daniëlle M. Gerlag et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

(2008) S. M. Ansell et al.   CLINICAL CANCER RESEARCH

Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis

(2008) Ivan Nestorov et al.   JOURNAL OF CLINICAL PHARMACOLOGY